Cargando…
1225. Optimization of Antimicrobial Therapy for Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Bloodstream Infections Through Laboratory-Based Interventions
BACKGROUND: In 2020, the Infectious Diseases Society of America (IDSA) published clinical practice guidance recommending up-front treatment with an IV carbapenem for severe infections with extended-spectrum β-lactamase (ESBL)-producing Enterobacterales (EB).(1) This single-center, observational stud...
Autores principales: | Yazdi, Mona, Wang, Rebecca, Martin, Isabella W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678119/ http://dx.doi.org/10.1093/ofid/ofad500.1065 |
Ejemplares similares
-
The Characteristics of Extended-Spectrum β-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream Infection
por: Li, Rongrong, et al.
Publicado: (2023) -
Laboratory antimicrobial resistance surveillance: extend spectrum beta lactamase (ESBL) producing E. coli
por: Mobasherizadeh, S, et al.
Publicado: (2011) -
Risk factors for predicting extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) infections in non-urinary isolates
por: Burgoon, Rachel, et al.
Publicado: (2023) -
Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
por: Paulitsch-Fuchs, Astrid H., et al.
Publicado: (2022) -
Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score
por: Haimerl, Brian J., et al.
Publicado: (2023)